The UK Health Security Agency has confirmed a meningitis outbreak in Kent with two deaths reported
Health officials have released an urgent update regarding the meningitis outbreak in Kent, deciding to expand a targeted rollout of antibiotics and vaccines. The UK Health Security Agency (UKHSA) has confirmed that the outbreak, which has sadly resulted in two fatalities, involves the MenB strain and is connected to a student nightclub.
Authorities have announced that eligibility for antibiotics, capable of halting the infection, and the MenB vaccine has been broadened in an attempt to control the spread. Updates on the situation are being provided daily.
Nightclub link and urgent antibiotic push
The outbreak has been partially traced back to people who visited Club Chemistry in Canterbury on March 5, 6 or 7. Anyone who was present – or who has had close contact with a confirmed or suspected case – is strongly encouraged to come forward for preventative antibiotics, which can prevent infection in up to 90% of cases.
Supplies are available at various locations including the University of Kent campus, hospitals and community clinics. Those who have since travelled elsewhere in the UK are being advised to immediately contact their GP to access treatment.
The UKHSA said: “A single course of antibiotics is highly effective in preventing the contraction and spread of this disease in 90% of cases. For MenB, prompt treatment with antibiotics is critical – which is why seeking urgent medical help at the first sign of symptoms is so important.”
Who will get the vaccine
A targeted immunisation programme is currently in progress, initially concentrating on students residing in halls at the University of Kent’s Canterbury campus. Health officials have indicated that this could be broadened in the forthcoming days depending on the progression of the outbreak.
Importantly, authorities have emphasised that Brits should not hastily seek to pay privately for the vaccine, as current measures – including antibiotics – are deemed the priority.
The UKHSA, which refuted claims of a vaccine shortage, said: “The vaccination programme may be expanded … and further advice on additional cohorts will be provided in the coming days. There are sufficient MenB vaccine stocks and we are working with local partners to ensure effective distribution to those who need it.”
What is MenB – and why it’s dangerous
Meningococcal disease is rare but extremely serious. It can lead to:
- Meningitis (infection of the brain lining)
- Sepsis (blood poisoning)
The illness can develop rapidly and become life-threatening within hours.
Unlike highly contagious infections such as COVID-19, MenB spreads through close and prolonged contact, such as:
- Living together
- Kissing
- Sharing drinks or vapes
Key symptoms people must not ignore
Officials are urging the public to remain vigilant and act fast if symptoms appear.
Warning signs include:
- A rash that does not fade when pressed
- Sudden high fever
- Severe headache
- Stiff neck
- Vomiting and diarrhoea
- Sensitivity to light
- Cold hands and feet
- Confusion or extreme drowsiness
Anyone experiencing these symptoms is told to seek urgent medical help by calling 999 or going to A&E immediately.
Risk to public ‘low’ – but vigilance essential
UKHSA said the overall risk to the wider public remains low, with efforts focused on tracing close contacts and preventing further spread. However, the agency stressed that speed is critical, with early treatment often lifesaving.
The MenB vaccine – introduced for babies in 2015 – has already led to a 75% reduction in cases amongst vaccinated groups, although it does not protect against all forms of meningitis.
Where to get help and advice
NHS guidance – here
Meningitis Research Foundation (24/7 helpline): 0808 800 3344
Meningitis Now: 0808 80 10 388
Officials say updates will continue to be published daily as the situation evolves.
You must be logged in to post a comment Login